Total accumulated dose of cisplatin and EXTREME regimen for recurrent and metastatic head and neck carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Total accumulated dose of cisplatin and EXTREME regimen for recurrent and metastatic head and neck carcinoma

Published:2022 Issue:3 Volume:31 Page:223-228
ISSN:1349-581X
Container-title:JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
language:en
Short-container-title:Toukeibu geka

Author:

Ando Takaaki¹,Saito Yuki¹,Sakai Toshihiko¹,Fukuoka Osamu¹,Akashi Ken²,Yoshida Masafumi³,Ando Mizuo¹,Yamasoba Tatsuya¹

Affiliation:

1. Department of Otolaryngology and Head and Neck Surgery, the University of Tokyo Hospital

2. Department of Otolaryngology and Head and Neck Surgery, Kameda General Hospital

3. Department of Otolaryngology and Head and Neck Surgery, Showa General Hospital

Publisher

Japan Society for Head and Neck Surgery

Subject

Management of Technology and Innovation

Link

https://www.jstage.jst.go.jp/article/jjshns/31/3/31_31.223/_pdf

Reference16 articles.

1. 1） Morton RP, Rugman F, Dorman EB, et al: Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomized factorial phase Ⅲ controlled trial. Cancer Chemother Pharmacol 15：283-289, 1985.

2. 2） Vermorken JB, Mesia R, Rivera F, et al: Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer. N Eng J Med 359：1116-1127, 2008.

3. 3） Bishnoi R, Bennett J, Reisman DN: Palliative treatment of patients with inoperative locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen. Oncol Lett 13：4633-4640, 2017.

4. 4） Yamamoto S, Umeda M, Kioi M, et al: Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma. Cancer Chemother Pharmacol 81：549-554, 2018.

5. 5）今村善宣，清田尚臣，丹生健一，他：当院における再発転移頭頸部扁平上皮癌に対する初回化学療法としてのセツキシマブ併用療法の遡及的検討．頭頸部癌，42：432-437，2016.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3